Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy

  1. de Wit, R.
  2. Powles, T.
  3. Castellano, D.
  4. Necchi, A.
  5. Lee, J.-L.
  6. van der Heijden, M.S.
  7. Matsubara, N.
  8. Bamias, A.
  9. Fléchon, A.
  10. Sternberg, C.N.
  11. Drakaki, A.
  12. Yu, E.Y.
  13. Zimmermann, A.H.
  14. Long, A.
  15. Walgren, R.A.
  16. Gao, L.
  17. Bell-McGuinn, K.M.
  18. Petrylak, D.P.
Aldizkaria:
British Journal of Clinical Pharmacology

ISSN: 1365-2125,  0306-5251

Argitalpen urtea: 2022

Alea: 88

Zenbakia: 7

Orrialdeak: 3182-3192

Mota: Artikulua

DOI: 10.1111/BCP.15233 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus